Strategic Acquisition KMK Consulting has become part of Tredence Inc., indicating potential cross-sell opportunities for analytics and decision-support services across a larger client base and extended capabilities in AI, data science, and life sciences.

Life Sciences Focus With deep experience in pharma, HEOR, Real World Evidence, and Sales Force Effectiveness, there is strong potential to upsell advanced analytics and commercialization optimization services to pharmaceutical and biopharma customers seeking data-driven market access and launch support.

Global Delivery A 200+ full-time global team enables scalable, on-site, or SaaS analytical engagements, offering flexibility to win multi-region contracts and expand into new geographies through Tredence’s international footprint.

Pain-Free Segmentation The launch of Pain-Free Segmentation signals a repeatable, customer-centric analytics framework that can be packaged as a service or product offering to current and prospective clients needing precise market and customer segmentation.

Recognition & Talent Recent leadership hires and a Great Place To Work certification bolster credibility for enterprise clients and can be leveraged to pursue higher-value engagements in health economics, evidence generation, and market access.